Journal of Clinical Immunology

, Volume 15, Issue 4, pp 205–209

No significant association between HLA antigens and classic kaposi sarcoma: Molecular analysis of 49 jewish patients

  • Liora Strichman-Almashanu
  • Sara Weltfriend
  • Osnat Gideoni
  • Rachel Friedman-Birnbaum
  • Shimon Pollack
Original Articles


Because of the abundance of the classical form of Kaposi sarcoma (CKS) among Jews and people of Mediterranean origin, studies have been conducted to find an association between CKS and HLA antigens. No conclusive results have been drawn, although in a number of these investigations an increased incidence of HLA-DR5 was reported. In our study 49 CKS patients of Jewish origin were serologically analyzed for HLA class I and class II antigens. We found no significant deviation in serologically defined HLA antigens frequencies between patients and 99 ethnically matched controls. However, a nonsignificant decrease in the frequencies of HLA-DR4, HLA-DR12, and the combination of DR4/DR11 was observed. Then we determined in these patients HLA-DRB1, HLADQA1, and DQB1 allelic polymorphism by oligotyping on PCR-amplified DNA. In this molecular analysis the only notable finding was a decreased frequency of the combination HLA-DQA1*0301/DQB1*0301, which appeared in one (2%) patient compared to 13 (13%) of the controls. However, the decrease was not statistically significant. On the basis of both serological and molecular analysis done on a relatively large group of CKS patients, we conclude that there is no significant linkage between HLA antigens and CKS in Jewish population.

Key words

HLA HLA-DR HLA-DQ antigens Kaposi sarcoma oligotyping Jews 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dalgleish AD: Kaposi's sarcoma. Br J Cancer 64:3–6, 1991PubMedGoogle Scholar
  2. 2.
    Armes J: A review of Kaposi's sarcoma. Adv Cancer Res 53:73–87, 1989PubMedGoogle Scholar
  3. 3.
    Tappero JW, Conant MA, Wolfe ST, Berger TG: Kaposi's sarcoma. J Am Acad Dermatol 28:371–395, 1993PubMedGoogle Scholar
  4. 4.
    Huang YQ, Li JI, Rush MG: HPV-16 related DNA sequences in Kaposi's sarcoma. Lancet 339:515–518, 1992PubMedGoogle Scholar
  5. 5.
    Contu L, Cerimele D, Pintus A, Cottoni F, La Nasa G: HLA and Kaposi's sarcoma in Sardinia. Tissue Antigens 23:240–245, 1984PubMedGoogle Scholar
  6. 6.
    Cerimele D, Contu L, Scappaticci S, Cottoni F: Kaposi's sarcoma in Sardinia: An epidemiologic and genetic investigation. Ann NY Acad Sci 437:216–227, 1984PubMedGoogle Scholar
  7. 7.
    Papasteriades C, Kaloterakis A, Filiotou A,et al.: Histocompatibility antigens HLA-A, -B, -DR in Greek patients with Kaposi's sarcoma. Tissue Antigens 24:313–315, 1984PubMedGoogle Scholar
  8. 8.
    Pollack MS, Safai B, Myskowsky PL, Gold JWM, Pandey J, Dupont B: Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma. Tissue Antigens 21:1–8, 1983PubMedGoogle Scholar
  9. 9.
    Marinig C, Fiorini G, Boneschi V, Melotti E, Brambilla L: Immunologic and immunogenetic features of primary Kaposi's sarcoma. Cancer 55:1899–1901, 1985PubMedGoogle Scholar
  10. 10.
    Tzfoni EE, Scherman L, Battat S, Brautbar H: No HLA antigen is significant in classic Kaposi's sarcoma. J Am Acad Dermatol 28:118–119, 1993PubMedGoogle Scholar
  11. 11.
    Johns MB Jr, Paulus-Thomas JE: Purification of human genomic DNA from whole blood using Sodium Perchlorate instead of Phenol. Anal Biochem 180:276–278, 1989PubMedGoogle Scholar
  12. 12.
    Tsuji K, Aizawa M, Sasazuki T (eds): HLA 1991—Proceedings of 11th International Histocompatibility Workshop and Conference. Oxford, Oxford University Press, 1992Google Scholar
  13. 13.
    Zetterquist H, Olerup O: Identification of the HLA-DRB1*04, DRB1*07, and DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol 34:64–74, 1992PubMedGoogle Scholar
  14. 14.
    Morel C, Zwahlen F, Jeannet M, Mach B, Tiercy JM: Complete analysis of HLA DQB1 polymorphism and DR-DQ linkage disequilibrium by oligonucleotide typing. Hum Immunol 29:64–77, 1990PubMedGoogle Scholar
  15. 15.
    Nepom GT, Erlich H: MHC class II molecules and autoimmunity. Annu Rev Immunol 9:493–525, 1991PubMedGoogle Scholar
  16. 16.
    Brenner S, Krakowsky A, Schewach-Millet M, Ronen M, Orgad S, Gazit E: Increased frequency of HLA-Awl9 in Kaposi's sarcoma. Tissue Antigens 19:392–394, 1982PubMedGoogle Scholar
  17. 17.
    Reinharz D, Tiercy JM, Mach B, Jeannet M: Absence of DRw15/3 and of DRw15/7 heterozygotes in Caucasian patients with systemic lupus erythematosus. Tissue Antigens 37:10–15, 1991PubMedGoogle Scholar
  18. 18.
    Thorsby E, Ronningen KS: Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to Type-1 (insulin dependent) diabetes mellitus. Diabetologia 36:371–377, 1993PubMedGoogle Scholar
  19. 19.
    Charron D: Molecular basis of human leukocyte antigen class II disease associations. Adv Immunol 48:107–159, 1990PubMedGoogle Scholar
  20. 20.
    Bell JI, Todd JA, McDevitt HO: The molecular basis of HLA-disease association. Adv Hum Genet 18:1–41, 1989PubMedGoogle Scholar
  21. 21.
    Cerimele D, Contu L, Carcassi C,et al.: HLA and multiple skin carcinomas. Dermatologica 176:176–181, 1988PubMedGoogle Scholar
  22. 22.
    Myskowsky PL, Pollack MS, Schorr E, Dupont B, Safai B: Human leukocyte antigen associations in basal cell carcinoma. J Am Acad Dermatol 12:997–1000, 1985PubMedGoogle Scholar
  23. 23.
    Czarnecki D, Lewis A, Nicholson I, Tait B: Multiple basal cell carcinomas and HLA frequencies in southern Australia. J Am Acad Dermatol 24:559–561, 1991PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1995

Authors and Affiliations

  • Liora Strichman-Almashanu
    • 1
    • 2
  • Sara Weltfriend
    • 3
  • Osnat Gideoni
    • 1
    • 2
  • Rachel Friedman-Birnbaum
    • 3
  • Shimon Pollack
    • 1
    • 2
  1. 1.Department of ImmunologyB. Rappaport Faculty of Medicine-TechnionHaifaIsrael
  2. 2.Tissue Typing LaboratoryB. Rappaport Faculty of Medicine-TechnionHaifaIsrael
  3. 3.Department of DermatologyRambam Medical CenterHaifaIsrael

Personalised recommendations